Transcranial Magnetic Stimulation trials

Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

RecruitingNCT03749538Phase: NAStarted 2018-10-01

Summary

Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
80 Years

Locations

Samuel K ShinjoSão Paulo, Brazil

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT03749538